MORRISVILLE, N.C.- November 3, 2023 - Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with P3 Research Ltd Network. The agreement further expands the Company's clinical trial capabilities across a broader range of therapeutic areas in New Zealand (NZ).

P3 Research Ltd Network now becomes part of the Syneos Health Catalyst and Site Network Partnerships program, including 110+ clinical sites and 60+ commercial site networks. As part of the Site Network Partnerships program, P3 Research Ltd Network joins a select set of high-performing investigative site networks strategically aligned to Syneos Health's clinical studies. Site Network Partnerships provide enhanced patient access, improved efficiencies, specialized expertise and access to diverse patient populations across all therapeutic areas and phases.

"The P3 Research Ltd Network is part of Syneos Health's global strategy to accelerate our clinical development impact in this rapidly growing and changing market," said Dr. Ken J. Lee, General Manager and Regional Head, Clinical Development, APAC, Syneos Health. "This collaboration supports our strong focus on customers, achieving consistent delivery and quality for their programs, while executing fit-for-purpose solutions that address their unique and complex needs."

P3 Research Ltd Network has been working for many years to grow and position NZ as a high-quality destination for conducting clinical trials. It has expanded its operations in NZ in recent years to include seven dedicated private research sites throughout provincial NZ.

Dr. Richard Stubbs, Managing Director of P3 Research Ltd Network, said, "NZ has for many years performed well in clinical trials. It is with both pleasure and pride that P3 Research will work with Syneos Health to facilitate efficient and successful clinical trial execution on behalf of customers in the region."

About Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.

Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients.

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.

Syneos Press/Media Contact:
 Gary Gatyas

Executive Director, External Communications
+1 908 763 3428

[email protected]

Attachments

Disclaimer

Syneos Health Inc. published this content on 03 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2023 21:23:35 UTC.